Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice

Neuropharmacology

Volumn 55, Issue 1, 2008, Pages 117-126

  Painsipp, Evelin ^a   Herzog, Herbert ^b   Holzer, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Anxiety related behavior; Bacterial lipopolysaccharide (endotoxin); Corticosterone; Depression like behavior; Fever; Locomotor behavior; Neuropeptide Y Y2 receptors; Neuropeptide Y Y4 receptors; Social interaction

Indexed keywords

CORTICOSTERONE; ENDOTOXIN; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DEPRESSION; EMOTION; ESCHERICHIA COLI; FEMALE; HYPERTHERMIA; IMMUNOCOMPETENCE; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RECTUM TEMPERATURE; SOCIAL BEHAVIOR; SOCIAL INTERACTION; STRESS;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CORTICOSTERONE; EXPLORATORY BEHAVIOR; FEMALE; FEVER; IMMOBILITY RESPONSE, TONIC; LIPOPOLYSACCHARIDES; LOCOMOTION; MAZE LEARNING; MICE; MICE, KNOCKOUT; RECEPTORS, NEUROPEPTIDE Y; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 45649084837     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.05.004     Document Type: Article

References (53)

1. Bedoui S., von Hörsten S., and Gebhardt T. A role for neuropeptide Y (NPY) in phagocytosis: implications for innate and adaptive immunity. Peptides 28 (2007) 373-376
2. Beishuizen A., and Thijs L.G. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J. Endotoxin Res. 9 (2003) 1-22
3. Belzung C., and Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125 (2001) 141-149
4. Borges B.C., Antunes-Rodrigues J., Castro M., Bittencourt J.C., Elias C.F., and Elias L.L. Expression of hypothalamic neuropeptides and the desensitization of pituitary-adrenal axis and hypophagia in the endotoxin tolerance. Horm. Behav. 52 (2007) 508-519
5. Campbell R.E., Smith M.S., Allen S.E., Grayson B.E., Ffrench-Mullen J.M., and Grove K.L. Orexin neurons express a functional pancreatic polypeptide Y4 receptor. J. Neurosci. 23 (2003) 1487-1497
6. Cryan J.F., Mombereau C., and Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 29 (2005) 571-625
7. DeFries J.C., Gervais M.C., and Thomas E.A. Response to 30 generations of selection for open-field activity in laboratory mice. Behav. Genet. 8 (1978) 3-13
8. Dunn A.J., and Swiergiel A.H. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol. Biochem. Behav. 81 (2005) 688-693
9. Dunn A.J., Swiergiel A.H., and de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies?. Neurosci. Biobehav. Rev. 29 (2005) 891-909
10. Felies M., von Hörsten S., Pabst R., and Nave H. Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats. J. Physiol. (Lond.) 561 (2004) 245-252
11. Fetissov S.O., Kopp J., and Hökfelt T. Distribution of NPY receptors in the hypothalamus. Neuropeptides 38 (2004) 175-188
12. Fishkin R.J., and Winslow J.T. Endotoxin-induced reduction of social investigation by mice: interaction with amphetamine and anti-inflammatory drugs. Psychopharmacology 132 (1997) 335-341
13. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., Kelley K.W., Dantzer R., and Castanon N. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32 (2007) 516-531
14. Fruhwald S., Herk E., Schöll G., Shahbazian A., Hammer H.F., Metzler H., and Holzer P. Endotoxin pretreatment modifies peristalsis and attenuates the antipropulsive action of adrenoceptor agonists in the guinea-pig small intestine. Neurogastroenterol. Motil. 16 (2004) 213-222
15. Goehler L.E., Gaykema R.P.A., Hansen M.K., Anderson K., Maier S.F., and Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. Basic Clin. 85 (2000) 49-59
16. Gustafson E.L., Smith K.E., Durkin M.M., Walker M.W., Gerald C., Weinshank R., and Branchek T.A. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Mol. Brain Res. 46 (1997) 223-235
17. Hays W.L. Statistics. sixth ed. (2007), Wadsworth, Belmont
18. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 38 (2004) 213-224
19. Jain N.K., Kulkarni S.K., and Singh A. Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors. Methods find. Exp. Clin. Pharmacol. 23 (2001) 441-444
20. Karl T., and Herzog H. Behavioral profiling of NPY in aggression and neuropsychiatric diseases. Peptides 28 (2007) 326-333
21. Kask A., Harro J., von Hörsten S., Redrobe J.P., Dumont Y., and Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci. Biobehav. Rev. 26 (2002) 259-283
22. Kim Y.W., Kim K.H., Ahn D.K., Kim H.S., Kim J.Y., Lee D.C., and Park S.Y. Time-course changes of hormones and cytokines by lipopolysaccharide and its relation with anorexia. J. Physiol. Sci. 57 (2007) 159-165
23. Kirk R.E. Experimental Design. Procedures for the Behavioral Sciences. Third ed. (1995), Brooks/Cole, Pacific Grove, California
24. Konsman J.P., and Dantzer R. How the immune and nervous systems interact during disease-associated anorexia. Nutrition 17 (2001) 664-668
25. Konsman J.P., Luheshi G.N., Bluthe R.M., and Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur. J. Neurosci. 12 (2000) 4434-4446
26. Konsman J.P., Parnet P., and Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25 (2002) 154-159
27. Lacosta S., Merali Z., and Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 818 (1999) 291-303
28. Lin S., Boey D., and Herzog H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38 (2004) 189-200
29. McCarthy H.D., Dryden S., and Williams G. Interleukin-1β-induced anorexia and pyrexia in rat: relationship to hypothalamic neuropeptide Y. Am. J. Physiol. 269 (1995) E852-E857
30. McMahon C.D., Buxton D.F., Elsasser T.H., Gunter D.R., Sanders L.G., Steele B.P., and Sartin J.L. Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep. J. Endocrinol. 161 (1999) 333-339
31. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., and Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50 (1998) 143-150
32. Mormede C., Palin K., Kelley K.W., Castanon N., and Dantzer R. Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice. Brain Behav. Immun. 18 (2004) 186-200
33. Nave H., Bedoui S., Moenter F., Steffens J., Felies M., Gebhardt T., Straub R.H., Pabst R., Dimitrijevic M., Stanojevic S., and von Hörsten S. Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation. J. Neuroimmunol. 155 (2004) 1-12
34. Olivier B., Zethof T., Pattij T., van Boogaert M., van Oorschot R., Leahy C., Oosting R., Bouwknecht A., Veening J., van der Gugten J., and Groenink L. Stress-induced hyperthermia and anxiety: pharmacological validation. Eur. J. Pharmacol. 463 (2003) 117-132
35. Painsipp, E., Wultsch, T., Edelsbrunner, M.E., Tasan, R.O., Singewald, N., Herzog, H., Holzer, P. Reduced anxiety-like and depression-related behavior in neuropeptide Y4 receptor knockout mice. Genes Brain Behav., in press.
36. Parker R.M., and Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 11 (1999) 1431-1448
37. Peloso E., Wachulec M., and Satinoff E. Stress-induced hyperthermia depends on both time of day and light condition. J. Biol. Rhythms 17 (2002) 164-170
38. Redrobe J.P., Carvajal C., Kask A., Dumont Y., and Quirion R. Neuropeptide Y and its receptor subtypes in the central nervous system: emphasis on their role in animal models of psychiatric disorders. In: Michel M.C. (Ed). Neuropeptide Y and Related Peptides. Handbook of Experimental Pharmacology vol. 162 (2004), Springer, Berlin 101-136
39. Redrobe J.P., Dumont Y., Herzog H., and Quirion R. Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav. Brain Res. 141 (2003) 251-255
40. Romanovsky A.A., Almeida M.C., Aronoff D.M., Ivanov A.I., Konsman J.P., Steiner A.A., and Turek V.F. Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front. Biosci. 10 (2005) 2193-2216
41. Sainsbury A., Schwarzer C., Couzens M., Fetissov S., Fürtinger S., Jenkins A., Cox H.M., Sperk G., Hökfelt T., and Herzog H. Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8938-8943
42. Sainsbury A., Schwarzer C., Couzens M., and Herzog H. Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes 51 (2002) 3420-3427
43. Sainsbury A., Schwarzer C., Couzens M., Jenkins A., Oakes S.R., Ormandy C.J., and Herzog H. Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev. 16 (2002) 1077-1088
44. Sergeyev V., Broberger C., and Hökfelt T. Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Mol. Brain Res. 90 (2001) 93-100
45. Sonti G., Ilyin S.E., and Plata-Salaman C.R. Neuropeptide Y blocks and reverses interleukin-1β-induced anorexia in rats. Peptides 17 (1996) 517-520
46. Stanic D., Brumovsky P., Fetissov S., Shuster S., Herzog H., and Hökfelt T. Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J. Comp. Neurol. 499 (2006) 357-390
47. Swiergiel A.H., and Dunn A.J. Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol. Biochem. Behav. 86 (2007) 651-659
48. Taché Y., Martinez V., Wang L., and Million M. CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br. J. Pharmacol. 141 (2004) 1321-1330
49. Teeling J.L., Felton L.M., Deacon R.M., Cunningham C., Rawlins J.N., and Perry V.H. Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav. Immun. 21 (2007) 836-850
50. Tschenett A., Singewald N., Carli M., Balducci C., Salchner P., Vezzani A., Herzog H., and Sperk G. Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur. J. Neurosci. 18 (2003) 143-148
51. Turnbull A.V., and Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79 (1999) 1-71
52. Whitcomb D.C., Puccio A.M., Vigna S.R., Taylor I.L., and Hoffman G.E. Distribution of pancreatic polypeptide receptors in the rat brain. Brain Res. 760 (1997) 137-149
53. Winer B.J., Brown D.R., and Michels K.M. Statistical Principles in Experimental Design. third ed. (1991), McGraw-Hill, New York